← Back to Screener
Cardio Diagnostics Holdings Inc. Warrant (CDIOW)
Price$0.02
Favorite Metrics
Price vs S&P 500 (26W)-12.87%
Price vs S&P 500 (4W)-26.60%
All Metrics
Price vs S&P 500 (YTD)-37.85%
10-Day Avg Trading Volume0.01M
3-Month Avg Trading Volume0.07M
52-Week High$0.07
26-Week Price Return-8.89%
13-Week Price Return-32.23%
3-Month Return Std Dev224.67%
Year-to-Date Return-36.68%
5-Day Price Return1.86%
Month-to-Date Return-0.61%
Price vs S&P 500 (13W)-32.92%
Beta1.79x
52-Week Low$0.01
Industry Peers — In Vitro Diagnostics(18)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
CDIOWCardio Diagnostics Holdings Inc. Warrant | — | — | — | — | $0.02 |
IDXXIdexx Laboratories Inc | 10.59x | 10.42% | 61.80% | 14.28% | $569.95 |
LNTHLantheus Holdings, Inc | 3.53x | 0.50% | 61.10% | 40.71% | $83.92 |
NNNNAnbio Biotechnology Class A Ordinary Shares | 299.06x | -5.72% | 89.00% | — | $27.80 |
CLDXCelldex Therapeutics, Inc | 1718.98x | -77.98% | 17.65% | — | $33.86 |
NEOGNeogen Corp | 2.32x | -3.91% | 45.20% | — | $9.24 |
NTLAIntellia Therapeutics, Inc | 26.08x | 16.92% | — | — | $14.16 |
QDELQuidelOrtho Corporation Common Stock | 0.31x | -1.89% | 46.67% | — | $12.69 |
MYGNMyriad Genetics Inc | 0.58x | -1.56% | 69.93% | — | $5.00 |
ACHVAchieve Life Sciences, Inc. | 14.37x | -89.25% | — | — | $4.81 |
TKNOAlpha Teknova, Inc. Common Stock | 3.62x | 7.35% | 33.17% | — | $2.68 |
About
Cardio Diagnostics Holdings develops AI-powered epigenetic blood tests for detecting and assessing coronary heart disease risk. The company's product suite includes Epi+Gen CHD for symptomatic risk assessment, PrecisionCHD for CHD detection, and Actionable Clinical Intelligence, a platform that delivers personalized patient insights by analyzing epigenetic and genetic biomarkers. These solutions aim to improve cardiovascular disease management and patient outcomes through advanced diagnostic capabilities.